CA Stock MarketDetailed Quotes
FRX Fennec Pharmaceuticals Inc
- 6.080
- -0.780-11.37%
15min DelayMarket Closed Nov 7 16:00 ET
166.38MMarket Cap63.33P/E (TTM)
6.530High5.900Low6.77KVolume6.530Open6.860Pre Close40.46KTurnover15.43052wk High0.04%Turnover Ratio27.36MShares5.76052wk Low0.096EPS TTM113.94MFloat Cap391.500Historical HighLossP/E (Static)18.74MShs Float0.270Historical Low-0.795EPS LYR9.18%Amplitude--Dividend TTM-88.12P/B1Lot Size--Div YieldTTM
Fennec Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -112.54%-8.39M | 800.14%39.05M | 5.07%-17.14M | 28.55%-4.86M | 44.91%-2.76M | -16.40%-3.95M | -95.27%-5.58M | -26.97%-18.06M | -109.61%-6.8M | -69.37%-5.01M |
| Net income from continuing operations | -2.00%-5.55M | 312.11%12.84M | 32.34%-16.05M | 60.89%-2.68M | 76.92%-1.87M | -7.33%-5.44M | -63.74%-6.05M | -36.71%-23.71M | -54.89%-6.86M | -93.29%-8.09M |
| Depreciation and amortization | 150.00%26K | 1,290.38%723K | ---- | ---- | ---- | ---52K | --52K | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | ---11K | -63.33%11K | -78.80%39K | -106.90%-4K | -51.85%13K | --0 | -67.03%30K | 636.00%184K | -64.20%58K | 169.23%27K |
| Remuneration paid in stock | -63.63%925K | 9.37%1.19M | 31.00%5.35M | 3.63%857K | -53.32%865K | 152.28%2.54M | 172.93%1.09M | 9.02%4.09M | -10.01%827K | 102.07%1.85M |
| Other non cashItems | 242.40%428K | 1,990.00%418K | 1.77%287K | -30.00%70K | -26.53%72K | 190.70%125K | -51.22%20K | 0.00%282K | -62.26%100K | 1,125.00%98K |
| Change In working capital | -276.83%-4.21M | 3,433.38%23.87M | -714.51%-6.78M | -233.44%-3.1M | -267.39%-1.84M | -279.45%-1.12M | -331.72%-716K | 218.35%1.1M | -467.07%-930K | 222.87%1.1M |
| -Change in receivables | -167.45%-2.04M | -957.97%-1.46M | -370.49%-7.27M | -177.61%-4.29M | ---2.08M | ---762K | ---138K | ---1.55M | ---1.55M | --0 |
| -Change in inventory | 84.64%-80K | 126.90%92K | -174.31%-1.58M | 30.38%-401K | ---316K | ---521K | ---342K | ---576K | ---576K | --0 |
| -Change in prepaid assets | -40.11%109K | -1,560.31%-1.91M | -60.61%104K | 14.84%-419K | -0.94%210K | -19.11%182K | -58.93%131K | 211.39%264K | -348.48%-492K | 125.76%212K |
| -Change in payables and accrued expense | -12,147.06%-2.08M | 654.50%2.04M | -33.51%1.96M | 19.27%2.01M | -61.46%343K | -104.24%-17K | -1,938.89%-367K | 526.26%2.95M | 566.94%1.68M | -23.67%890K |
| -Change in other current assets | ---122K | ---133K | -50.00%3K | 50.00%3K | --0 | --0 | --0 | 400.00%6K | 200.00%2K | 50.00%-1K |
| -Change in other current liabilities | --0 | --25.25M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -112.54%-8.39M | 800.14%39.05M | 5.07%-17.14M | 28.55%-4.86M | 44.91%-2.76M | -16.40%-3.95M | -95.27%-5.58M | -26.97%-18.06M | -109.61%-6.8M | -69.37%-5.01M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -50.00%257K | -686.53%-1.13M | -67.98%6.64M | 595.39%5.73M | -98.99%201K | 1,017.39%514K | 1,186.67%193K | 316.47%20.73M | 8,140.00%824K | 19.85M |
| Net issuance payments of debt | ---- | ---- | -74.93%5M | 7,787.69%5M | ---- | ---- | ---- | 298.70%19.94M | ---65K | ---- |
| Proceeds from stock option exercised by employees | -35.86%347K | 194.37%627K | 84.91%1.72M | 10.01%747K | 14.36%215K | 1,076.09%541K | 1,320.00%213K | 2,712.12%928K | 7,444.44%679K | --188K |
| Net other financing activities | -233.33%-90K | -8,695.00%-1.76M | 42.75%-75K | -106.67%-14K | ---14K | ---27K | ---20K | -138.18%-131K | 20,900.00%210K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -50.00%257K | -686.53%-1.13M | -67.98%6.64M | 595.39%5.73M | -98.99%201K | 1,017.39%514K | 1,186.67%193K | 316.47%20.73M | 8,140.00%824K | --19.85M |
| Net cash flow | ||||||||||
| Beginning cash position | 178.33%51.18M | -44.19%13.27M | 12.67%23.77M | -58.33%12.4M | 0.29%14.96M | 0.72%18.39M | 12.67%23.77M | -30.46%21.1M | 22.26%29.75M | -45.35%14.92M |
| Current changes in cash | -136.89%-8.13M | 804.22%37.92M | -492.86%-10.51M | 114.55%870K | -117.25%-2.56M | -2.63%-3.43M | -89.51%-5.38M | 128.93%2.67M | -84.79%-5.98M | 601.59%14.84M |
| End cash Position | 187.83%43.05M | 178.33%51.18M | -44.19%13.27M | -44.19%13.27M | -58.33%12.4M | 0.29%14.96M | 0.72%18.39M | 12.67%23.77M | 12.67%23.77M | 22.26%29.75M |
| Free cash from | -112.54%-8.39M | 800.14%39.05M | 5.07%-17.14M | 28.55%-4.86M | 44.91%-2.76M | -16.40%-3.95M | -95.27%-5.58M | -26.97%-18.06M | -109.61%-6.8M | -69.37%-5.01M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data